{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:32:57Z","timestamp":1769243577428,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["1U51PS004633-01"],"award-info":[{"award-number":["1U51PS004633-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["1U51PS004633-01"],"award-info":[{"award-number":["1U51PS004633-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["1U51PS004633-01"],"award-info":[{"award-number":["1U51PS004633-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["UL1TR001860"],"award-info":[{"award-number":["UL1TR001860"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To measure the effect of an electronic health record (EHR) alert on chronic hepatitis B (CHB) screening among at-risk Asian and Pacific Islanders (API). API patients who had not yet completed hepatitis B surface antigen (HBsAg) testing were identified by a novel EHR-based population health tool. At-risk API patients in Cohort 1 (primarily privately insured) and Cohort 2 (includes Medicare and\/or Medicaid) were randomized to alert activation in their electronic medical charts or not. In total, 8299 API were found to be deficient in HBsAg completion at baseline within our health system. In Cohort 1, 1542 patients and 1568 patients were randomized to the alert and control respectively. In Cohort 2, 2599 patients and 2590 patients were randomized to the alert and control respectively. For both cohorts combined, 389 HBsAg tests were completed in the alert group compared to 177 HBsAg tests in the control group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001; OR\u2009=\u20092.3; 95% CI 1.94\u20132.80), but there was no increased detection of HBsAg positivity from the alert (15 versus 13 respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.09; OR\u2009=\u20090.5; 95% CI 0.24\u20131.09). Our results demonstrate that personalized, automated electronic alerts increase screening for CHB, but more comprehensive measures are needed to detect HBsAg positive patients.<\/jats:p><jats:p><jats:bold>NIH Trial Registry Number<\/jats:bold>: NCT04240678.<\/jats:p>","DOI":"10.1038\/s41598-020-75842-8","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:03:19Z","timestamp":1604574199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Electronic health record alerts enhance mass screening for chronic hepatitis B"],"prefix":"10.1038","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04240678","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eric","family":"Chak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Shang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Moon S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"75842_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.28109","volume":"63","author":"H Roberts","year":"2016","unstructured":"Roberts, H. et al. Prevalence of chronic hepatitis B virus (Hbv) infection in U.S. households: National Health and Nutrition Examination Survey (Nhanes), 1988\u20132012. Hepatology 63, 388\u2013397 (2016).","journal-title":"Hepatology"},{"key":"75842_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.24804","volume":"56","author":"KV Kowdley","year":"2012","unstructured":"Kowdley, K. V., Wang, C. C., Welch, S., Roberts, H. & Brosgart, C. L. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 56, 422\u2013433 (2012).","journal-title":"Hepatology"},{"key":"75842_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"key":"75842_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ajg.2014.11","volume":"109","author":"SF Altekruse","year":"2014","unstructured":"Altekruse, S. F., Henley, S. J., Cucinelli, J. E. & Mcglynn, K. A. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am. J. Gastroenterol. 109, 542\u2013553 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"75842_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10900-005-9000-6","volume":"31","author":"H Chen","year":"2006","unstructured":"Chen, H. et al. Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention. J. Community Health 31, 94\u2013112 (2006).","journal-title":"J. Community Health"},{"key":"75842_CR6","first-page":"127","volume":"8","author":"CA Wu","year":"2007","unstructured":"Wu, C. A., Lin, S. Y., So, S. K. & Chang, E. T. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac. J. Cancer Prev. 8, 127\u2013134 (2007).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"75842_CR7","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.3748\/wjg.v21.i22.6914","volume":"21","author":"SD Chao","year":"2015","unstructured":"Chao, S. D., Wang, B. M., Chang, E. T., Ma, L. & So, S. K. Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World J. Gastroenterol. 21, 6914\u20136923 (2015).","journal-title":"World J. Gastroenterol."},{"key":"75842_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3810\/pgm.2010.09.2213","volume":"122","author":"N Upadhyaya","year":"2010","unstructured":"Upadhyaya, N. et al. Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians. Postgrad. Med. 122, 165\u2013175 (2010).","journal-title":"Postgrad. Med."},{"key":"75842_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/1055-9965.EPI-18-0448","volume":"27","author":"E Chak","year":"2018","unstructured":"Chak, E. et al. Electronic medical alerts increase screening for chronic hepatitis B: a randomized, double-blind, controlled trial. Cancer Epidemiol. Biomarkers Prev. 27, 1352\u20131357 (2018).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"75842_CR10","unstructured":"Jensen, T., Chin, J., Ashby, L., Paserchia, L., Issa, M. Decision memo for screening for hepatitis B virus (HBV) infection (CAG-00447N) (The Centers for Medicare and Medicaid Services (CMS), September 28, 2016)."},{"key":"75842_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/A:1026582308352","volume":"19","author":"D Lauderdale","year":"2000","unstructured":"Lauderdale, D. & Kestenbaum, B. Asian American ethnic identification by surname. Popul. Res. Policy Rev. 19, 283\u2013300 (2000).","journal-title":"Popul. Res. Policy Rev."},{"key":"75842_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/MLR.0b013e3181d559e9","volume":"48","author":"EC Wong","year":"2010","unstructured":"Wong, E. C., Palaniappan, L. P. & Lauderdale, D. S. Using name lists to infer Asian racial\/ethnic subgroups in the healthcare setting. Med. Care 48, 540\u2013546 (2010).","journal-title":"Med. Care"},{"key":"75842_CR13","doi-asserted-by":"publisher","first-page":"42-2288-10-42","DOI":"10.1186\/1471-2288-10-42","volume":"10","author":"BR Shah","year":"2010","unstructured":"Shah, B. R. et al. Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med. Res. Methodol. 10, 42-2288-10\u201342 (2010).","journal-title":"BMC Med. Res. Methodol."},{"key":"75842_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10620-012-2396-9","volume":"58","author":"L Hsu","year":"2013","unstructured":"Hsu, L. et al. Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig. Dis. Sci. 58, 807\u2013814 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"75842_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/jamia.2009.000695","volume":"17","author":"BL Strom","year":"2010","unstructured":"Strom, B. L. et al. Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAID\u2014warfarin co-prescribing as a test case. J. Am. Med. Inform. Assoc. 17, 411\u2013415 (2010).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"75842_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa041533","volume":"352","author":"N Kucher","year":"2005","unstructured":"Kucher, N. et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N. Engl. J. Med. 352, 969\u2013977 (2005).","journal-title":"N. Engl. J. Med."},{"key":"75842_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1542\/peds.2007-0257","volume":"120","author":"AG Fiks","year":"2007","unstructured":"Fiks, A. G., Grundmeier, R. W., Biggs, L. M., Localio, A. R. & Alessandrini, E. A. Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics 120, 707\u2013714 (2007).","journal-title":"Pediatrics"},{"key":"75842_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.28880","volume":"65","author":"JE Brady","year":"2017","unstructured":"Brady, J. E. et al. Uptake of hepatitis c screening, characteristics of patients tested, and intervention costs in the best-C study. Hepatology 65, 44\u201353 (2017).","journal-title":"Hepatology"},{"issue":"549\u201352","key":"75842_CR19","first-page":"563","volume":"51","author":"Centers for Disease Control and Prevention (Cdc)","year":"2002","unstructured":"Centers for Disease Control and Prevention (Cdc). Hepatitis B vaccination-United States, 1982\u20132002. Mmwr Morb. Mortal. Wkly. Rep. 51(549\u201352), 563 (2002).","journal-title":"Mmwr Morb. Mortal. Wkly. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75842-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:41:19Z","timestamp":1670366479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75842-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75842-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eric Chak MD, MPH: Gilead Sciences (Research Contract). All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19153"}}